pharmaceutical investing Marinus Pharmaceuticals Initiates Phase 3 Study in Children with PCDH19-Related Epilepsy
Summit Royalties Secures Up to US$50 Million Revolving Credit Facility; Provides Other Corporate Updates
NextSource Materials Announces Updated Feasibility Study Results for Molo Mine Expansion to 150k tpa of SuperFlake Graphite Concentrate